Paid Clinical Trials Houston

Discover 3,033 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,033

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Houston TX, Tomball TX, Galveston TX, Beaumont TXshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

Venous EthanolVenous Ethanol for Ventricular Tachycardia

Recruiting

PHASE2

Sponsor:

The Methodist Hospital Research Institute

Location:

Houston TX

Code:

NCT05511246

Conditions

Ventricular Tachycardia

Ischemic Cardiomyopathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Venous ethanol

Catheter ablation

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Houston TX, San Antonio TX, Dallas TX, Richardson TXshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

Adoptive Cord BloodAdoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Recruiting

PHASE1

PHASE2

Sponsor:

Catherine Bollard

Location:

Houston TX, Washington DC

Code:

NCT03594981

Conditions

Viral Infection

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

CMV/AdV /EBV/BKV specific T cells

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Houston TX, Temple TX, San Antonio TX, Dallas TXshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Houston TX, Kansas City MO, Aurora CO, Hinsdale ILshow 10 more

Code:

NCT04557462

Conditions

Primary IgA Nephropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LNP023

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Houston TX, Dallas TX, Nashville TN, Ocala FLshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Houston TX, San Antonio TX, Birmingham AL, Iowa City IAshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Houston TX, Lake Charles LA, Austin TX, Shavano Park TXshow 29 more

Code:

NCT06074562

Conditions

Diabetic Peripheral Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3556050

Placebo

CX-4945Dose-escalation Study of Oral CX-4945

Recruiting

PHASE1

Sponsor:

Cylene Pharmaceuticals

Location:

Houston TX, Loveland CO, Fort Collins CO, Scottsdale AZ

Code:

NCT00891280

Conditions

Advanced Solid Tumors

Breast Cancer

Inflammatory Breast Cancer

Castleman's Disease

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CX-4945 oral formulation

Inflammation TreatmentA Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Recruiting

PHASE2

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

Houston TX, Atlanta GA, Philadelphia PA, Basking Ridge NJshow 7 more

Code:

NCT05787574

Conditions

Primary Immune Regulatory Disorder

Autoimmune Lymphoproliferative

Immune System Diseases

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Emapalumab

Fludarabine and Dexamethasone

Stem Cell Transplant